

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | skeletal muscle adaptation (GO:0043501) | 9.79057758 |
| 2 | skeletal muscle fiber development (GO:0048741) | 9.58111804 |
| 3 | actin filament-based movement (GO:0030048) | 8.21431522 |
| 4 | myotube cell development (GO:0014904) | 8.16055839 |
| 5 | plasma membrane repair (GO:0001778) | 7.95719756 |
| 6 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 7.15302415 |
| 7 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.84848649 |
| 8 | striated muscle atrophy (GO:0014891) | 6.69634462 |
| 9 | sarcomere organization (GO:0045214) | 6.66118897 |
| 10 | skeletal muscle tissue regeneration (GO:0043403) | 6.60836585 |
| 11 | * striated muscle contraction (GO:0006941) | 6.53378041 |
| 12 | response to inactivity (GO:0014854) | 6.34843627 |
| 13 | glycogen catabolic process (GO:0005980) | 6.13607012 |
| 14 | response to muscle activity (GO:0014850) | 5.93933203 |
| 15 | muscle atrophy (GO:0014889) | 5.89551081 |
| 16 | purine nucleotide salvage (GO:0032261) | 5.89186800 |
| 17 | creatine metabolic process (GO:0006600) | 5.87099781 |
| 18 | myofibril assembly (GO:0030239) | 5.81757440 |
| 19 | glucan catabolic process (GO:0009251) | 5.73895436 |
| 20 | * muscle contraction (GO:0006936) | 5.73317045 |
| 21 | muscle fiber development (GO:0048747) | 5.55177243 |
| 22 | striated muscle adaptation (GO:0014888) | 5.51811200 |
| 23 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.51672070 |
| 24 | regulation of cell communication by electrical coupling (GO:0010649) | 5.49250613 |
| 25 | neutrophil activation involved in immune response (GO:0002283) | 5.38925910 |
| 26 | cellular polysaccharide catabolic process (GO:0044247) | 5.35863375 |
| 27 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.34217886 |
| 28 | carnitine shuttle (GO:0006853) | 5.30852820 |
| 29 | cytidine deamination (GO:0009972) | 5.14857973 |
| 30 | cytidine metabolic process (GO:0046087) | 5.14857973 |
| 31 | cytidine catabolic process (GO:0006216) | 5.14857973 |
| 32 | IMP metabolic process (GO:0046040) | 5.11675278 |
| 33 | * muscle system process (GO:0003012) | 5.09969275 |
| 34 | polysaccharide catabolic process (GO:0000272) | 5.09127431 |
| 35 | glucan biosynthetic process (GO:0009250) | 4.97906195 |
| 36 | glycogen biosynthetic process (GO:0005978) | 4.97906195 |
| 37 | actomyosin structure organization (GO:0031032) | 4.86103947 |
| 38 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.82149734 |
| 39 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.67875528 |
| 40 | muscle cell fate commitment (GO:0042693) | 4.63441592 |
| 41 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.61990166 |
| 42 | positive regulation of myotube differentiation (GO:0010831) | 4.60082080 |
| 43 | regulation of skeletal muscle cell differentiation (GO:2001014) | 4.57307440 |
| 44 | * regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.51161804 |
| 45 | muscle adaptation (GO:0043500) | 4.45922896 |
| 46 | myotube differentiation (GO:0014902) | 4.41750464 |
| 47 | muscle organ development (GO:0007517) | 4.41286954 |
| 48 | neuromuscular synaptic transmission (GO:0007274) | 4.41064097 |
| 49 | fatty acid transmembrane transport (GO:1902001) | 4.39826648 |
| 50 | muscle cell cellular homeostasis (GO:0046716) | 4.38159489 |
| 51 | muscle structure development (GO:0061061) | 4.34149008 |
| 52 | skeletal muscle tissue development (GO:0007519) | 4.31092701 |
| 53 | myoblast fusion (GO:0007520) | 4.22398897 |
| 54 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.22112776 |
| 55 | glycogen metabolic process (GO:0005977) | 4.21361751 |
| 56 | glucan metabolic process (GO:0044042) | 4.12739401 |
| 57 | cellular glucan metabolic process (GO:0006073) | 4.12739401 |
| 58 | striated muscle cell development (GO:0055002) | 4.07030638 |
| 59 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.02792906 |
| 60 | IMP biosynthetic process (GO:0006188) | 4.01689975 |
| 61 | neuronal action potential propagation (GO:0019227) | 3.96528185 |
| 62 | positive regulation of myoblast differentiation (GO:0045663) | 3.94455810 |
| 63 | response to activity (GO:0014823) | 3.91828276 |
| 64 | negative regulation of skeletal muscle tissue development (GO:0048642) | 3.89861147 |
| 65 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.88485900 |
| 66 | regulation of relaxation of muscle (GO:1901077) | 3.87954865 |
| 67 | carnitine transmembrane transport (GO:1902603) | 3.85474520 |
| 68 | cardiac muscle contraction (GO:0060048) | 3.81752753 |
| 69 | regulation of coenzyme metabolic process (GO:0051196) | 3.81733120 |
| 70 | regulation of cofactor metabolic process (GO:0051193) | 3.81733120 |
| 71 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.75669445 |
| 72 | syncytium formation (GO:0006949) | 3.74095047 |
| 73 | negative regulation of muscle hypertrophy (GO:0014741) | 3.73559172 |
| 74 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.68898183 |
| 75 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.60527563 |
| 76 | negative regulation of cell killing (GO:0031342) | 3.59289667 |
| 77 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59289667 |
| 78 | muscle cell development (GO:0055001) | 3.50865146 |
| 79 | neutrophil activation (GO:0042119) | 3.49622186 |
| 80 | carnitine transport (GO:0015879) | 3.49376356 |
| 81 | amino-acid betaine transport (GO:0015838) | 3.49376356 |
| 82 | regulation of myoblast differentiation (GO:0045661) | 3.49141380 |
| 83 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.45247547 |
| 84 | granulocyte activation (GO:0036230) | 3.44023746 |
| 85 | neuromuscular junction development (GO:0007528) | 3.43736990 |
| 86 | cellular carbohydrate catabolic process (GO:0044275) | 3.40624988 |
| 87 | cellular response to dexamethasone stimulus (GO:0071549) | 3.39728428 |
| 88 | negative regulation of interleukin-12 production (GO:0032695) | 3.37762775 |
| 89 | tricarboxylic acid cycle (GO:0006099) | 3.35386429 |
| 90 | regulation of striated muscle contraction (GO:0006942) | 3.33298181 |
| 91 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.27580208 |
| 92 | protein neddylation (GO:0045116) | 3.25755842 |
| 93 | positive regulation of mast cell activation (GO:0033005) | 3.25555667 |
| 94 | skeletal muscle cell differentiation (GO:0035914) | 3.22842555 |
| 95 | cardiac myofibril assembly (GO:0055003) | 3.22150457 |
| 96 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.20532449 |
| 97 | response to dexamethasone (GO:0071548) | 3.14266506 |
| 98 | immunoglobulin mediated immune response (GO:0016064) | 3.11083881 |
| 99 | response to peptidoglycan (GO:0032494) | 3.08709756 |
| 100 | regulation of actin filament-based movement (GO:1903115) | 3.07992348 |
| 101 | regulation of sulfur metabolic process (GO:0042762) | 3.07896509 |
| 102 | regulation of chronic inflammatory response (GO:0002676) | 3.06744797 |
| 103 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05564907 |
| 104 | regulation of myotube differentiation (GO:0010830) | 3.03521169 |
| 105 | cellular polysaccharide biosynthetic process (GO:0033692) | 3.00307072 |
| 106 | heart process (GO:0003015) | 2.99595433 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 2.96058675 |
| 108 | regulation of platelet activation (GO:0010543) | 2.86869236 |
| 109 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.79600573 |
| 110 | negative regulation of thymocyte apoptotic process (GO:0070244) | 2.79359118 |
| 111 | germinal center formation (GO:0002467) | 2.79205551 |
| 112 | regulation of platelet aggregation (GO:0090330) | 2.79145473 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.78492644 |
| 114 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.70671244 |
| 115 | positive regulation of mast cell degranulation (GO:0043306) | 2.70671244 |
| 116 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.67357567 |
| 117 | lipoxygenase pathway (GO:0019372) | 2.67311705 |
| 118 | B cell mediated immunity (GO:0019724) | 2.67184877 |
| 119 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.67129064 |
| 120 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.65290909 |
| 121 | positive regulation of B cell mediated immunity (GO:0002714) | 2.63782676 |
| 122 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.63782676 |
| 123 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.63708610 |
| 124 | leukocyte degranulation (GO:0043299) | 2.62462410 |
| 125 | myeloid cell activation involved in immune response (GO:0002275) | 2.61110421 |
| 126 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.60531145 |
| 127 | mitochondrial calcium ion transport (GO:0006851) | 2.57993038 |
| 128 | NIK/NF-kappaB signaling (GO:0038061) | 2.56031366 |
| 129 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.56001158 |
| 130 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.55890439 |
| 131 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.53411407 |
| 132 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.53255647 |
| 133 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.52268316 |
| 134 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.51351144 |
| 135 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.49317187 |
| 136 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.48956780 |
| 137 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.48948816 |
| 138 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.48170984 |
| 139 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.44849806 |
| 140 | leukocyte aggregation (GO:0070486) | 2.42995026 |
| 141 | positive regulation of macrophage differentiation (GO:0045651) | 2.42480034 |
| 142 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.41879850 |
| 143 | adenosine receptor signaling pathway (GO:0001973) | 2.41002564 |
| 144 | phagosome maturation (GO:0090382) | 2.39318630 |
| 145 | purine-containing compound salvage (GO:0043101) | 2.38037813 |
| 146 | N-acetylneuraminate metabolic process (GO:0006054) | 2.37708407 |
| 147 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.37696625 |
| 148 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.37353444 |
| 149 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.37079100 |
| 150 | adenosine metabolic process (GO:0046085) | 2.36601787 |
| 151 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.35369251 |
| 152 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.35348655 |
| 153 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.34346900 |
| 154 | cellular response to arsenic-containing substance (GO:0071243) | 2.33655369 |
| 155 | purinergic receptor signaling pathway (GO:0035587) | 2.32828657 |
| 156 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.32607416 |
| 157 | glycosphingolipid catabolic process (GO:0046479) | 2.32155116 |
| 158 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.29946743 |
| 159 | tolerance induction (GO:0002507) | 2.29809761 |
| 160 | autophagic vacuole fusion (GO:0000046) | 2.28921618 |
| 161 | regulation of leukocyte degranulation (GO:0043300) | 2.28839143 |
| 162 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.28729236 |
| 163 | polyamine biosynthetic process (GO:0006596) | 2.28481585 |
| 164 | regulation of interleukin-12 production (GO:0032655) | 2.26806246 |
| 165 | type I interferon signaling pathway (GO:0060337) | 2.26659011 |
| 166 | cellular response to type I interferon (GO:0071357) | 2.26659011 |
| 167 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.26216793 |
| 168 | lymphocyte chemotaxis (GO:0048247) | 2.25583567 |
| 169 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.25178760 |
| 170 | positive regulation of isotype switching (GO:0045830) | 2.23440447 |
| 171 | positive regulation of interleukin-17 production (GO:0032740) | 2.23240240 |
| 172 | negative regulation of T cell apoptotic process (GO:0070233) | 2.22795810 |
| 173 | positive regulation of DNA recombination (GO:0045911) | 2.21990496 |
| 174 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.21832450 |
| 175 | negative regulation of platelet activation (GO:0010544) | 2.21505949 |
| 176 | response to type I interferon (GO:0034340) | 2.21483752 |
| 177 | positive regulation of interleukin-10 production (GO:0032733) | 2.21041256 |
| 178 | muscle filament sliding (GO:0030049) | 13.4751766 |
| 179 | actin-myosin filament sliding (GO:0033275) | 13.4751766 |
| 180 | regulation of skeletal muscle contraction (GO:0014819) | 12.0996846 |
| 181 | * skeletal muscle contraction (GO:0003009) | 11.0997105 |
| 182 | actin-mediated cell contraction (GO:0070252) | 11.0296429 |
| 183 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 10.6224943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 8.45733050 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08875071 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.86044887 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85490650 |
| 5 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.74950262 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.60309395 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.18323556 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.12387272 |
| 9 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.83259476 |
| 10 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.76335433 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.72117625 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.68061733 |
| 13 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 2.52846427 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.50114465 |
| 15 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.50114465 |
| 16 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.49094928 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.45452973 |
| 18 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.43679239 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.41440491 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.39488715 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.35855857 |
| 22 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.34793581 |
| 23 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.32890763 |
| 24 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30470016 |
| 25 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.24565215 |
| 26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.22096026 |
| 27 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17005241 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.16182372 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.16094363 |
| 30 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.14496319 |
| 31 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09618839 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.09381112 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.99156067 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.98768905 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98449341 |
| 36 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.97647577 |
| 37 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97054073 |
| 38 | SPI1_23127762_ChIP-Seq_K562_Human | 1.94913776 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94671971 |
| 40 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.90340348 |
| 41 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.90165435 |
| 42 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.84974509 |
| 43 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.84215489 |
| 44 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.83842618 |
| 45 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.83677008 |
| 46 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.80757786 |
| 47 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.78356868 |
| 48 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.78046821 |
| 49 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.77155065 |
| 50 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.76271734 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.70778996 |
| 52 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.69490894 |
| 53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66839004 |
| 54 | MAF_26560356_Chip-Seq_TH1_Human | 1.65568177 |
| 55 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.63390253 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.61484419 |
| 57 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.61088563 |
| 58 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.60813883 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.60738391 |
| 60 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.59099408 |
| 61 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58712013 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58546384 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.57642269 |
| 64 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.56508653 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.55596294 |
| 66 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.52824438 |
| 67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52666803 |
| 68 | MYB_26560356_Chip-Seq_TH2_Human | 1.52530419 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51285048 |
| 70 | SA1_27219007_Chip-Seq_Bcells_Human | 1.51100521 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.46573062 |
| 72 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.46422075 |
| 73 | UTX_26944678_Chip-Seq_JUKART_Human | 1.45497715 |
| 74 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.44812000 |
| 75 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.42322336 |
| 76 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.42262876 |
| 77 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.42201243 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41645402 |
| 79 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41097852 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.40960206 |
| 81 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38470178 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.37981952 |
| 83 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.37793502 |
| 84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.37511334 |
| 85 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.36534265 |
| 86 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36131677 |
| 87 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.34139330 |
| 88 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.33173878 |
| 89 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32251208 |
| 90 | * FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.31510082 |
| 91 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.30267077 |
| 92 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30229823 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.29514348 |
| 94 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.29464483 |
| 95 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.29404765 |
| 96 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29262050 |
| 97 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.28373464 |
| 98 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.27696315 |
| 99 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.27249606 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.26391626 |
| 101 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.25966647 |
| 102 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25841804 |
| 103 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.25182424 |
| 104 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.24174048 |
| 105 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23796081 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23211303 |
| 107 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21345968 |
| 108 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.20932199 |
| 109 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.20480155 |
| 110 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.20390454 |
| 111 | GATA3_26560356_Chip-Seq_TH2_Human | 1.20001669 |
| 112 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19508146 |
| 113 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19479271 |
| 114 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.19120229 |
| 115 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.18765851 |
| 116 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.18271245 |
| 117 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.18109423 |
| 118 | * MAF_26560356_Chip-Seq_TH2_Human | 1.16827308 |
| 119 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.15004220 |
| 120 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.14887615 |
| 121 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14631032 |
| 122 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14620295 |
| 123 | MYC_22102868_ChIP-Seq_BL_Human | 1.12851322 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12488332 |
| 125 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11829792 |
| 126 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.10662840 |
| 127 | MYB_26560356_Chip-Seq_TH1_Human | 1.10476432 |
| 128 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.10268290 |
| 129 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.09454967 |
| 130 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09191019 |
| 131 | ATF3_27146783_Chip-Seq_COLON_Human | 1.07889506 |
| 132 | P300_27268052_Chip-Seq_Bcells_Human | 1.07856241 |
| 133 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07182913 |
| 134 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.05683765 |
| 135 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.05683765 |
| 136 | P68_20966046_ChIP-Seq_HELA_Human | 1.05545587 |
| 137 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04133599 |
| 138 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.03972591 |
| 139 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03481810 |
| 140 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.03309428 |
| 141 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.02437982 |
| 142 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02224627 |
| 143 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00548036 |
| 144 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.00362602 |
| 145 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.00227236 |
| 146 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99514022 |
| 147 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.99349452 |
| 148 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.99302788 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99036904 |
| 150 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.98087289 |
| 151 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.97327474 |
| 152 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.97105143 |
| 153 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.97022833 |
| 154 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96880523 |
| 155 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96317418 |
| 156 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.95833407 |
| 157 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.95483978 |
| 158 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.94695907 |
| 159 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94657676 |
| 160 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.94559665 |
| 161 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94348831 |
| 162 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93898051 |
| 163 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.93896080 |
| 164 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92946363 |
| 165 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.92747275 |
| 166 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.92017507 |
| 167 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.91328077 |
| 168 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90566345 |
| 169 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90479313 |
| 170 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.90065253 |
| 171 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.88945447 |
| 172 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87692258 |
| 173 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85706237 |
| 174 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.85178420 |
| 175 | CJUN_26792858_Chip-Seq_BT549_Human | 0.84745724 |
| 176 | KDM2B_26808549_Chip-Seq_K562_Human | 0.83926483 |
| 177 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83828596 |
| 178 | * RAC3_21632823_ChIP-Seq_H3396_Human | 0.83578491 |
| 179 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.81680852 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 8.13845477 |
| 2 | MP0000749_muscle_degeneration | 6.74122425 |
| 3 | MP0000751_myopathy | 6.02759078 |
| 4 | MP0003646_muscle_fatigue | 5.83949286 |
| 5 | * MP0002106_abnormal_muscle_physiology | 4.25800107 |
| 6 | * MP0000747_muscle_weakness | 4.14778082 |
| 7 | MP0000759_abnormal_skeletal_muscle | 4.05250416 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.82997483 |
| 9 | MP0000750_abnormal_muscle_regeneration | 3.67573315 |
| 10 | MP0005464_abnormal_platelet_physiology | 3.66467714 |
| 11 | MP0002269_muscular_atrophy | 3.65917751 |
| 12 | * MP0005369_muscle_phenotype | 3.55420606 |
| 13 | MP0004087_abnormal_muscle_fiber | 3.53909351 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 3.39692203 |
| 15 | MP0003303_peritoneal_inflammation | 3.35664704 |
| 16 | MP0003724_increased_susceptibility_to | 3.34686642 |
| 17 | MP0004130_abnormal_muscle_cell | 3.11052542 |
| 18 | MP0001835_abnormal_antigen_presentation | 3.08630819 |
| 19 | MP0005620_abnormal_muscle_contractility | 3.05020516 |
| 20 | MP0000733_abnormal_muscle_development | 3.04125108 |
| 21 | MP0003436_decreased_susceptibility_to | 2.89198417 |
| 22 | MP0004233_abnormal_muscle_weight | 2.82054011 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.81176896 |
| 24 | MP0005058_abnormal_lysosome_morphology | 2.77642472 |
| 25 | MP0005451_abnormal_body_composition | 2.73064762 |
| 26 | MP0005671_abnormal_response_to | 2.63901200 |
| 27 | MP0000685_abnormal_immune_system | 2.40595929 |
| 28 | MP0009785_altered_susceptibility_to | 2.40248775 |
| 29 | MP0005000_abnormal_immune_tolerance | 2.37414647 |
| 30 | MP0002108_abnormal_muscle_morphology | 2.20008661 |
| 31 | MP0001790_abnormal_immune_system | 2.11328393 |
| 32 | MP0005387_immune_system_phenotype | 2.11328393 |
| 33 | MP0002332_abnormal_exercise_endurance | 2.09539706 |
| 34 | MP0002419_abnormal_innate_immunity | 1.98049918 |
| 35 | MP0002723_abnormal_immune_serum | 1.95051320 |
| 36 | MP0001800_abnormal_humoral_immune | 1.94854992 |
| 37 | MP0005025_abnormal_response_to | 1.91776400 |
| 38 | MP0004270_analgesia | 1.91487767 |
| 39 | MP0002452_abnormal_antigen_presenting | 1.88275492 |
| 40 | MP0009840_abnormal_foam_cell | 1.88263194 |
| 41 | MP0005330_cardiomyopathy | 1.88249562 |
| 42 | MP0001533_abnormal_skeleton_physiology | 1.86849225 |
| 43 | MP0009764_decreased_sensitivity_to | 1.86156547 |
| 44 | MP0008004_abnormal_stomach_pH | 1.83841246 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.76072042 |
| 46 | MP0009333_abnormal_splenocyte_physiolog | 1.69139155 |
| 47 | MP0003075_altered_response_to | 1.68097221 |
| 48 | MP0004084_abnormal_cardiac_muscle | 1.67906163 |
| 49 | MP0006082_CNS_inflammation | 1.67122830 |
| 50 | MP0001819_abnormal_immune_cell | 1.63368045 |
| 51 | MP0002420_abnormal_adaptive_immunity | 1.63120480 |
| 52 | MP0010155_abnormal_intestine_physiology | 1.62740925 |
| 53 | MP0001845_abnormal_inflammatory_respons | 1.57577459 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.51935136 |
| 55 | MP0002971_abnormal_brown_adipose | 1.49594028 |
| 56 | MP0004947_skin_inflammation | 1.46989486 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.42275530 |
| 58 | MP0003300_gastrointestinal_ulcer | 1.38549799 |
| 59 | MP0004215_abnormal_myocardial_fiber | 1.36883959 |
| 60 | MP0005167_abnormal_blood-brain_barrier | 1.35254882 |
| 61 | MP0008469_abnormal_protein_level | 1.33357549 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.26931133 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.26822775 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.25224255 |
| 65 | MP0002972_abnormal_cardiac_muscle | 1.24931838 |
| 66 | MP0004484_altered_response_of | 1.21583617 |
| 67 | MP0010630_abnormal_cardiac_muscle | 1.20868104 |
| 68 | MP0002398_abnormal_bone_marrow | 1.19856976 |
| 69 | MP0000716_abnormal_immune_system | 1.19211621 |
| 70 | MP0000013_abnormal_adipose_tissue | 1.19104508 |
| 71 | MP0002139_abnormal_hepatobiliary_system | 1.13309028 |
| 72 | MP0003763_abnormal_thymus_physiology | 1.11736841 |
| 73 | MP0000858_altered_metastatic_potential | 1.10147180 |
| 74 | MP0002998_abnormal_bone_remodeling | 1.09643097 |
| 75 | MP0000689_abnormal_spleen_morphology | 1.08750581 |
| 76 | MP0002405_respiratory_system_inflammati | 1.08228970 |
| 77 | MP0003950_abnormal_plasma_membrane | 1.08108322 |
| 78 | MP0009278_abnormal_bone_marrow | 1.06707888 |
| 79 | MP0002234_abnormal_pharynx_morphology | 1.05868139 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03324872 |
| 81 | MP0005165_increased_susceptibility_to | 1.03160764 |
| 82 | MP0002429_abnormal_blood_cell | 1.03050747 |
| 83 | MP0005375_adipose_tissue_phenotype | 1.02615260 |
| 84 | MP0005266_abnormal_metabolism | 1.01398110 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 0.98919721 |
| 86 | MP0001853_heart_inflammation | 0.97059231 |
| 87 | MP0001663_abnormal_digestive_system | 0.96552735 |
| 88 | MP0008260_abnormal_autophagy | 0.94098970 |
| 89 | MP0005397_hematopoietic_system_phenotyp | 0.91901547 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.91901547 |
| 91 | MP0002722_abnormal_immune_system | 0.91789900 |
| 92 | MP0004134_abnormal_chest_morphology | 0.91766668 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.90596495 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.89976604 |
| 95 | MP0003806_abnormal_nucleotide_metabolis | 0.89883776 |
| 96 | MP0009763_increased_sensitivity_to | 0.89726049 |
| 97 | MP0005310_abnormal_salivary_gland | 0.84966416 |
| 98 | MP0009250_abnormal_appendicular_skeleto | 0.81956778 |
| 99 | MP0005385_cardiovascular_system_phenoty | 0.81871263 |
| 100 | MP0001544_abnormal_cardiovascular_syste | 0.81871263 |
| 101 | MP0001299_abnormal_eye_distance/ | 0.80557298 |
| 102 | MP0003186_abnormal_redox_activity | 0.80513093 |
| 103 | MP0008961_abnormal_basal_metabolism | 0.77366645 |
| 104 | MP0002693_abnormal_pancreas_physiology | 0.77192631 |
| 105 | MP0000249_abnormal_blood_vessel | 0.77010833 |
| 106 | MP0000372_irregular_coat_pigmentation | 0.76070197 |
| 107 | MP0003448_altered_tumor_morphology | 0.75661402 |
| 108 | MP0004147_increased_porphyrin_level | 0.74145299 |
| 109 | MP0003705_abnormal_hypodermis_morpholog | 0.73982699 |
| 110 | MP0001542_abnormal_bone_strength | 0.72856676 |
| 111 | MP0001873_stomach_inflammation | 0.72485222 |
| 112 | MP0005390_skeleton_phenotype | 0.72379732 |
| 113 | MP0003137_abnormal_impulse_conducting | 0.71809981 |
| 114 | MP0003195_calcinosis | 0.70876417 |
| 115 | MP0003866_abnormal_defecation | 0.70464408 |
| 116 | MP0000762_abnormal_tongue_morphology | 0.67092255 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.66134835 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.65994766 |
| 119 | MP0005275_abnormal_skin_tensile | 0.60334451 |
| 120 | MP0005670_abnormal_white_adipose | 0.57777876 |
| 121 | MP0005334_abnormal_fat_pad | 0.54846755 |
| 122 | MP0000266_abnormal_heart_morphology | 0.53081405 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.51309042 |
| 124 | MP0008569_lethality_at_weaning | 0.50088693 |
| 125 | MP0002114_abnormal_axial_skeleton | 0.49576375 |
| 126 | MP0002127_abnormal_cardiovascular_syste | 0.48888989 |
| 127 | MP0002089_abnormal_postnatal_growth/wei | 0.47329161 |
| 128 | MP0004043_abnormal_pH_regulation | 0.47051256 |
| 129 | MP0005452_abnormal_adipose_tissue | 0.46240019 |
| 130 | MP0002896_abnormal_bone_mineralization | 0.40484509 |
| 131 | MP0003959_abnormal_lean_body | 0.38850109 |
| 132 | MP0000343_altered_response_to | 0.38803927 |
| 133 | MP0006138_congestive_heart_failure | 0.38075928 |
| 134 | MP0008775_abnormal_heart_ventricle | 0.36356729 |
| 135 | MP0003948_abnormal_gas_homeostasis | 0.35177201 |
| 136 | MP0009672_abnormal_birth_weight | 0.34622414 |
| 137 | MP0003045_fibrosis | 0.33015849 |
| 138 | MP0002249_abnormal_larynx_morphology | 0.32681478 |
| 139 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.32217574 |
| 140 | MP0004510_myositis | 0.31618668 |
| 141 | MP0004142_abnormal_muscle_tone | 0.31074448 |
| 142 | MP0005319_abnormal_enzyme/_coenzyme | 0.30855154 |
| 143 | MP0001849_ear_inflammation | 0.30507090 |
| 144 | MP0009115_abnormal_fat_cell | 0.29510901 |
| 145 | MP0001943_abnormal_respiration | 0.29113635 |
| 146 | MP0004085_abnormal_heartbeat | 0.27902407 |
| 147 | MP0009780_abnormal_chondrocyte_physiolo | 0.27595488 |
| 148 | MP0005503_abnormal_tendon_morphology | 0.27394399 |
| 149 | MP0010030_abnormal_orbit_morphology | 0.27232494 |
| 150 | MP0001243_abnormal_dermal_layer | 0.26787156 |
| 151 | MP0005083_abnormal_biliary_tract | 0.26194981 |
| 152 | MP0002932_abnormal_joint_morphology | 0.24157814 |
| 153 | MP0003828_pulmonary_edema | 0.23609600 |
| 154 | MP0002128_abnormal_blood_circulation | 0.23471618 |
| 155 | MP0003755_abnormal_palate_morphology | 0.23409206 |
| 156 | MP0004197_abnormal_fetal_growth/weight/ | 0.22973023 |
| 157 | MP0008770_decreased_survivor_rate | 0.22777477 |
| 158 | MP0003567_abnormal_fetal_cardiomyocyte | 0.22367545 |
| 159 | MP0002734_abnormal_mechanical_nocicepti | 0.21745354 |
| 160 | MP0003385_abnormal_body_wall | 0.20973999 |
| 161 | MP0005376_homeostasis/metabolism_phenot | 0.19135365 |
| 162 | MP0000678_abnormal_parathyroid_gland | 0.18613691 |
| 163 | MP0000230_abnormal_systemic_arterial | 0.18108604 |
| 164 | MP0002109_abnormal_limb_morphology | 0.17505946 |
| 165 | MP0003879_abnormal_hair_cell | 0.16610886 |
| 166 | MP0005535_abnormal_body_temperature | 0.16610795 |
| 167 | MP0005166_decreased_susceptibility_to | 0.16326045 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 9.88485308 |
| 2 | Nemaline bodies (HP:0003798) | 9.33587322 |
| 3 | Exercise-induced myalgia (HP:0003738) | 7.91765368 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 7.67254184 |
| 5 | Distal arthrogryposis (HP:0005684) | 7.55850681 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 7.09070922 |
| 7 | Myopathic facies (HP:0002058) | 6.72056143 |
| 8 | Round ear (HP:0100830) | 6.45071139 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.42413485 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 6.38909956 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 5.76862476 |
| 12 | Calcaneovalgus deformity (HP:0001848) | 5.57223523 |
| 13 | Difficulty running (HP:0009046) | 5.30047092 |
| 14 | Deformed tarsal bones (HP:0008119) | 5.10389963 |
| 15 | Muscle fiber splitting (HP:0003555) | 5.06211206 |
| 16 | Absent phalangeal crease (HP:0006109) | 5.05743627 |
| 17 | Hyporeflexia of lower limbs (HP:0002600) | 4.64213391 |
| 18 | Myoglobinuria (HP:0002913) | 4.57420525 |
| 19 | EMG: myopathic abnormalities (HP:0003458) | 4.50980544 |
| 20 | Malignant hyperthermia (HP:0002047) | 4.40768359 |
| 21 | Muscle stiffness (HP:0003552) | 4.25893309 |
| 22 | Petechiae (HP:0000967) | 4.23743910 |
| 23 | Abnormal finger flexion creases (HP:0006143) | 4.23628588 |
| 24 | Increased connective tissue (HP:0009025) | 4.17858282 |
| 25 | Abnormality of the calf musculature (HP:0001430) | 4.10540083 |
| 26 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.06147150 |
| 27 | Myotonia (HP:0002486) | 3.86219894 |
| 28 | Rhabdomyolysis (HP:0003201) | 3.85098265 |
| 29 | Prolonged bleeding time (HP:0003010) | 3.83809964 |
| 30 | Difficulty climbing stairs (HP:0003551) | 3.64318394 |
| 31 | Neck muscle weakness (HP:0000467) | 3.53583434 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.53558931 |
| 33 | Purpura (HP:0000979) | 3.53089197 |
| 34 | Stomatitis (HP:0010280) | 3.46433786 |
| 35 | Fatigable weakness (HP:0003473) | 3.39982096 |
| 36 | Abnormality of the neuromuscular junction (HP:0003398) | 3.39982096 |
| 37 | Abnormality of the calcaneus (HP:0008364) | 3.38654974 |
| 38 | Fetal akinesia sequence (HP:0001989) | 3.37163891 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 3.35365381 |
| 40 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.35365381 |
| 41 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.35365381 |
| 42 | Subaortic stenosis (HP:0001682) | 3.20325996 |
| 43 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.20325996 |
| 44 | Frequent falls (HP:0002359) | 3.19548085 |
| 45 | Rimmed vacuoles (HP:0003805) | 3.19021556 |
| 46 | Shoulder girdle muscle weakness (HP:0003547) | 3.17390185 |
| 47 | Pelvic girdle muscle weakness (HP:0003749) | 3.15112658 |
| 48 | Abnormality of macrophages (HP:0004311) | 3.11672061 |
| 49 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.05079011 |
| 50 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.05079011 |
| 51 | Areflexia of lower limbs (HP:0002522) | 2.96535796 |
| 52 | Menorrhagia (HP:0000132) | 2.86301862 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.82714417 |
| 54 | Epistaxis (HP:0000421) | 2.80072682 |
| 55 | Weak cry (HP:0001612) | 2.79001585 |
| 56 | Slender build (HP:0001533) | 2.78451513 |
| 57 | Bulbar palsy (HP:0001283) | 2.76715530 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.64485184 |
| 59 | Hyperkalemia (HP:0002153) | 2.64275658 |
| 60 | Abnormal platelet volume (HP:0011876) | 2.60370971 |
| 61 | Increased serum ferritin (HP:0003281) | 2.58256577 |
| 62 | Gowers sign (HP:0003391) | 2.57537381 |
| 63 | Eczematoid dermatitis (HP:0000976) | 2.54569938 |
| 64 | Asymmetric septal hypertrophy (HP:0001670) | 2.54558386 |
| 65 | Increased mean platelet volume (HP:0011877) | 2.53422506 |
| 66 | Generalized muscle weakness (HP:0003324) | 2.52294270 |
| 67 | Recurrent abscess formation (HP:0002722) | 2.51076076 |
| 68 | EMG: neuropathic changes (HP:0003445) | 2.49397567 |
| 69 | Type 2 muscle fiber atrophy (HP:0003554) | 2.47183910 |
| 70 | Recurrent bacterial skin infections (HP:0005406) | 2.46957668 |
| 71 | Dysostosis multiplex (HP:0000943) | 2.45057400 |
| 72 | Distal lower limb muscle weakness (HP:0009053) | 2.43454151 |
| 73 | Abnormality of lateral ventricle (HP:0030047) | 2.42821817 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 2.38770592 |
| 75 | Increased cerebral lipofuscin (HP:0011813) | 2.37497476 |
| 76 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.35158890 |
| 77 | Myositis (HP:0100614) | 2.33539282 |
| 78 | Nonprogressive disorder (HP:0003680) | 2.33516620 |
| 79 | Sudden death (HP:0001699) | 2.32269076 |
| 80 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.26509512 |
| 81 | Muscular dystrophy (HP:0003560) | 2.23418603 |
| 82 | Retrobulbar optic neuritis (HP:0100654) | 2.23293520 |
| 83 | Optic neuritis (HP:0100653) | 2.23293520 |
| 84 | Paralysis (HP:0003470) | 2.22254054 |
| 85 | Muscle fiber atrophy (HP:0100295) | 2.22238434 |
| 86 | Spinal rigidity (HP:0003306) | 2.21287457 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 2.20027785 |
| 88 | Orchitis (HP:0100796) | 2.19102874 |
| 89 | Facial diplegia (HP:0001349) | 2.18632774 |
| 90 | Increased intramyocellular lipid droplets (HP:0012240) | 2.18397975 |
| 91 | Limb-girdle muscle weakness (HP:0003325) | 2.17078438 |
| 92 | Scapular winging (HP:0003691) | 2.15833821 |
| 93 | Metatarsus adductus (HP:0001840) | 2.15652397 |
| 94 | Obstructive lung disease (HP:0006536) | 2.14209594 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.14209594 |
| 96 | Proximal amyotrophy (HP:0007126) | 2.13548907 |
| 97 | Hypoplastic ischia (HP:0003175) | 2.13090792 |
| 98 | Popliteal pterygium (HP:0009756) | 2.13081117 |
| 99 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.12918524 |
| 100 | Ulnar deviation of finger (HP:0009465) | 2.12849563 |
| 101 | Hepatosplenomegaly (HP:0001433) | 2.12027749 |
| 102 | Limb-girdle muscle atrophy (HP:0003797) | 2.10722805 |
| 103 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10422542 |
| 104 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.10119505 |
| 105 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.10074898 |
| 106 | Hyperlipoproteinemia (HP:0010980) | 2.09418274 |
| 107 | Nausea (HP:0002018) | 2.07702569 |
| 108 | Increased muscle lipid content (HP:0009058) | 2.06414147 |
| 109 | Muscle fibrillation (HP:0010546) | 2.05665101 |
| 110 | Generalized aminoaciduria (HP:0002909) | 2.04185386 |
| 111 | Gingival bleeding (HP:0000225) | 2.00246197 |
| 112 | Hip contracture (HP:0003273) | 2.00241782 |
| 113 | Muscle fiber inclusion bodies (HP:0100299) | 10.2091950 |
| 114 | Mediastinal lymphadenopathy (HP:0100721) | 1.97232715 |
| 115 | Tongue fasciculations (HP:0001308) | 1.96517885 |
| 116 | Increased IgM level (HP:0003496) | 1.96159192 |
| 117 | Encephalitis (HP:0002383) | 1.96044093 |
| 118 | Long clavicles (HP:0000890) | 1.92739993 |
| 119 | Progressive muscle weakness (HP:0003323) | 1.89794244 |
| 120 | Impaired platelet aggregation (HP:0003540) | 1.88849039 |
| 121 | Abnormal platelet function (HP:0011869) | 1.88849039 |
| 122 | Abnormal pupillary function (HP:0007686) | 1.88610107 |
| 123 | Waddling gait (HP:0002515) | 1.88499344 |
| 124 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.87045232 |
| 125 | Spontaneous hematomas (HP:0007420) | 1.86145584 |
| 126 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.84205285 |
| 127 | Abnormality of the ischium (HP:0003174) | 1.84024945 |
| 128 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.82792653 |
| 129 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.82792653 |
| 130 | Easy fatigability (HP:0003388) | 1.79352447 |
| 131 | Polyneuropathy (HP:0001271) | 1.78509539 |
| 132 | Abnormality of placental membranes (HP:0011409) | 1.78081584 |
| 133 | Amniotic constriction ring (HP:0009775) | 1.78081584 |
| 134 | Ragged-red muscle fibers (HP:0003200) | 1.78072860 |
| 135 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.76553892 |
| 136 | Exercise intolerance (HP:0003546) | 1.76203885 |
| 137 | Hepatic necrosis (HP:0002605) | 1.75019747 |
| 138 | Loss of speech (HP:0002371) | 1.73984042 |
| 139 | Tarsal synostosis (HP:0008368) | 1.70864930 |
| 140 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.70666634 |
| 141 | Achilles tendon contracture (HP:0001771) | 1.69300368 |
| 142 | Lower limb amyotrophy (HP:0007210) | 1.66451662 |
| 143 | Increased density of long bones (HP:0006392) | 1.65571438 |
| 144 | Short palpebral fissure (HP:0012745) | 1.57691490 |
| 145 | Synostosis involving bones of the feet (HP:0009140) | 1.54211679 |
| 146 | Synostosis involving bones of the lower limbs (HP:0009138) | 1.54211679 |
| 147 | Adducted thumb (HP:0001181) | 1.54102045 |
| 148 | Abnormality of the Achilles tendon (HP:0005109) | 1.52174927 |
| 149 | Congenital hip dislocation (HP:0001374) | 1.51091210 |
| 150 | Aplasia of the musculature (HP:0100854) | 1.49223769 |
| 151 | Cholelithiasis (HP:0001081) | 1.43944694 |
| 152 | Webbed neck (HP:0000465) | 1.43682118 |
| 153 | Breech presentation (HP:0001623) | 1.42092869 |
| 154 | Stridor (HP:0010307) | 1.41918572 |
| 155 | Ventricular tachycardia (HP:0004756) | 1.39991310 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 8.64078406 |
| 2 | TTN | 6.19781022 |
| 3 | PHKG2 | 5.11746439 |
| 4 | PHKG1 | 5.11746439 |
| 5 | NME1 | 4.27532022 |
| 6 | PIK3CG | 4.26477792 |
| 7 | RIPK4 | 3.43771435 |
| 8 | MAP2K3 | 2.89694533 |
| 9 | MUSK | 2.60469049 |
| 10 | IRAK3 | 2.53923496 |
| 11 | TLK1 | 2.45145991 |
| 12 | TAOK3 | 2.35248061 |
| 13 | TRIB3 | 2.31775015 |
| 14 | NEK1 | 2.27853093 |
| 15 | PINK1 | 2.22899184 |
| 16 | MAP3K7 | 2.10491071 |
| 17 | IKBKB | 2.04472381 |
| 18 | TBK1 | 1.92068407 |
| 19 | MST4 | 1.90443155 |
| 20 | MAP3K14 | 1.77997292 |
| 21 | PDK4 | 1.75974156 |
| 22 | PDK3 | 1.75974156 |
| 23 | MAP4K1 | 1.73807626 |
| 24 | MAPK12 | 1.71249312 |
| 25 | TXK | 1.69038440 |
| 26 | ZAP70 | 1.68421168 |
| 27 | TESK2 | 1.64699524 |
| 28 | DMPK | 1.62144243 |
| 29 | NME2 | 1.57830641 |
| 30 | MAP2K6 | 1.53305064 |
| 31 | MAP2K4 | 1.53059972 |
| 32 | PIK3CA | 1.52312868 |
| 33 | IRAK4 | 1.47124170 |
| 34 | GRK6 | 1.45877258 |
| 35 | BMPR2 | 1.43844305 |
| 36 | CSF1R | 1.42787489 |
| 37 | BCKDK | 1.39673664 |
| 38 | SYK | 1.39672122 |
| 39 | BLK | 1.35487736 |
| 40 | MOS | 1.34485924 |
| 41 | BTK | 1.33527563 |
| 42 | IKBKE | 1.32450941 |
| 43 | MYLK | 1.28317952 |
| 44 | MAP3K12 | 1.24886279 |
| 45 | ADRBK2 | 1.19206509 |
| 46 | PDK2 | 1.09822029 |
| 47 | MAPKAPK3 | 1.04341704 |
| 48 | ARAF | 1.03089309 |
| 49 | VRK2 | 1.00375316 |
| 50 | TYK2 | 0.99893536 |
| 51 | MATK | 0.99644892 |
| 52 | GRK7 | 0.97658150 |
| 53 | MARK3 | 0.96900287 |
| 54 | TNK2 | 0.96637529 |
| 55 | SIK3 | 0.95327736 |
| 56 | LYN | 0.92880204 |
| 57 | FGR | 0.92321334 |
| 58 | HCK | 0.91073809 |
| 59 | ERN1 | 0.90435542 |
| 60 | TEC | 0.90208859 |
| 61 | DAPK2 | 0.90135982 |
| 62 | CSK | 0.89059590 |
| 63 | FES | 0.86498706 |
| 64 | MAP3K3 | 0.85947258 |
| 65 | MAP4K2 | 0.85795009 |
| 66 | TESK1 | 0.85620809 |
| 67 | NEK9 | 0.84795822 |
| 68 | PKN2 | 0.82229997 |
| 69 | PRKAA2 | 0.76376084 |
| 70 | DAPK1 | 0.75368240 |
| 71 | MAP2K2 | 0.74491201 |
| 72 | JAK3 | 0.73869996 |
| 73 | AKT2 | 0.73205856 |
| 74 | TAOK2 | 0.72845168 |
| 75 | PRKAA1 | 0.72400259 |
| 76 | ABL2 | 0.72346537 |
| 77 | TRPM7 | 0.72278191 |
| 78 | ERBB3 | 0.71405689 |
| 79 | DAPK3 | 0.70767499 |
| 80 | EEF2K | 0.69042542 |
| 81 | KIT | 0.64968563 |
| 82 | CDK8 | 0.64870141 |
| 83 | MAPK11 | 0.64680752 |
| 84 | ILK | 0.63100955 |
| 85 | TAOK1 | 0.60206164 |
| 86 | STK24 | 0.56948543 |
| 87 | PAK1 | 0.56114622 |
| 88 | ZAK | 0.55194194 |
| 89 | LCK | 0.55081535 |
| 90 | CAMK2G | 0.54665949 |
| 91 | EIF2AK1 | 0.53157089 |
| 92 | PRPF4B | 0.52028548 |
| 93 | MAP3K11 | 0.51922968 |
| 94 | MAP2K1 | 0.51809677 |
| 95 | GRK5 | 0.51455652 |
| 96 | CHUK | 0.49980222 |
| 97 | ITK | 0.49761517 |
| 98 | JAK1 | 0.49585729 |
| 99 | EPHB1 | 0.46793403 |
| 100 | ACVR1B | 0.46526555 |
| 101 | MAP3K13 | 0.44186297 |
| 102 | RIPK1 | 0.43925278 |
| 103 | LIMK1 | 0.42936531 |
| 104 | HIPK2 | 0.40511290 |
| 105 | IRAK1 | 0.40211598 |
| 106 | MAP3K10 | 0.38442614 |
| 107 | IRAK2 | 0.38006380 |
| 108 | PTK6 | 0.35296097 |
| 109 | STK16 | 0.34794725 |
| 110 | KSR2 | 0.34570588 |
| 111 | SIK2 | 0.32282812 |
| 112 | JAK2 | 0.30344906 |
| 113 | MAP3K1 | 0.29478574 |
| 114 | SGK1 | 0.29453043 |
| 115 | MAP3K5 | 0.28965270 |
| 116 | SIK1 | 0.28384924 |
| 117 | RPS6KA3 | 0.28036161 |
| 118 | PRKG1 | 0.27542194 |
| 119 | PRKACB | 0.27329931 |
| 120 | MAPK7 | 0.27082861 |
| 121 | DYRK1B | 0.25283108 |
| 122 | MAP3K6 | 0.22003462 |
| 123 | MAPK4 | 0.21822815 |
| 124 | TGFBR2 | 0.21372989 |
| 125 | ROCK1 | 0.20538355 |
| 126 | PDPK1 | 0.18725815 |
| 127 | PDK1 | 0.18081307 |
| 128 | PKN1 | 0.17516252 |
| 129 | PRKACA | 0.16455761 |
| 130 | LATS1 | 0.15250616 |
| 131 | LRRK2 | 0.14521728 |
| 132 | TIE1 | 0.13908500 |
| 133 | CCNB1 | 0.12079002 |
| 134 | CAMK1G | 0.10910550 |
| 135 | PAK6 | 0.10668226 |
| 136 | PTK2B | 0.09930041 |
| 137 | ICK | 0.09894455 |
| 138 | KSR1 | 0.09684719 |
| 139 | MTOR | 0.09446853 |
| 140 | RPS6KB2 | 0.08263866 |
| 141 | MAPK10 | 0.07836073 |
| 142 | PRKD1 | 0.07426992 |
| 143 | PIM2 | 0.07159618 |
| 144 | RPS6KA1 | 0.06864402 |
| 145 | MAP3K9 | 0.06757767 |
| 146 | ROCK2 | 0.06513261 |
| 147 | FGFR1 | 0.06451619 |
| 148 | BMX | 0.05810519 |
| 149 | CDK19 | 0.05245046 |
| 150 | CAMK2D | 0.04689586 |
| 151 | MAPK8 | 0.03939088 |
| 152 | CDK6 | 0.03914296 |
| 153 | PAK4 | 0.03435650 |
| 154 | CDK14 | 0.01901993 |
| 155 | CDK15 | 0.01201369 |
| 156 | LATS2 | 0.01171591 |
| 157 | MAPK9 | 0.00893104 |
| 158 | CDK11A | 0.00746170 |
| 159 | PRKACG | 0.00368022 |
| 160 | RPS6KA2 | 0.00019322 |
| 161 | CDK18 | -0.0116815 |
| 162 | CAMK2A | -0.0089907 |
| 163 | SGK3 | -0.0077187 |
| 164 | CSNK1D | -0.0065341 |
| 165 | STK11 | -0.0030809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.71078348 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.17895841 |
| 3 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 4.15794312 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.85993331 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.79793213 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.20427702 |
| 7 | Asthma_Homo sapiens_hsa05310 | 3.10537730 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 3.02120367 |
| 9 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.88608311 |
| 10 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.88396994 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.68403429 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.62931750 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.51850722 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.50548025 |
| 15 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.42723355 |
| 16 | Circadian rhythm_Homo sapiens_hsa04710 | 2.38774165 |
| 17 | Insulin signaling pathway_Homo sapiens_hsa04910 | 2.32596744 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.30254052 |
| 19 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.27103862 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.17104250 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 2.12956150 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 2.06597892 |
| 23 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 2.04142581 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.01087617 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.99720627 |
| 26 | Insulin resistance_Homo sapiens_hsa04931 | 1.97605263 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.96388275 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.95912944 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.95373488 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94741331 |
| 31 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.94491453 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.94357775 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.81662299 |
| 34 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.80274948 |
| 35 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.78805878 |
| 36 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.77219801 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.74693483 |
| 38 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.74301215 |
| 39 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.71355670 |
| 40 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.70313593 |
| 41 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.70256290 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.69606900 |
| 43 | Galactose metabolism_Homo sapiens_hsa00052 | 1.69589517 |
| 44 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.68940535 |
| 45 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.68239517 |
| 46 | Tuberculosis_Homo sapiens_hsa05152 | 1.64842463 |
| 47 | Parkinsons disease_Homo sapiens_hsa05012 | 1.63302884 |
| 48 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.55180967 |
| 49 | Alzheimers disease_Homo sapiens_hsa05010 | 1.53098215 |
| 50 | Tight junction_Homo sapiens_hsa04530 | 1.51832754 |
| 51 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51511539 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49202967 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44692138 |
| 54 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42174901 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.40994137 |
| 56 | Malaria_Homo sapiens_hsa05144 | 1.39657800 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.34099306 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.32853187 |
| 59 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.32285270 |
| 60 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.26658697 |
| 61 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.25994678 |
| 62 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.25070973 |
| 63 | Phagosome_Homo sapiens_hsa04145 | 1.24888509 |
| 64 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.24533871 |
| 65 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.24525823 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 1.23527733 |
| 67 | Focal adhesion_Homo sapiens_hsa04510 | 1.21759050 |
| 68 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18690879 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.17052091 |
| 70 | Proteasome_Homo sapiens_hsa03050 | 1.11647369 |
| 71 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.10909776 |
| 72 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.08153815 |
| 73 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07553583 |
| 74 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04682964 |
| 75 | Shigellosis_Homo sapiens_hsa05131 | 1.01672782 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.01320682 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00393334 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.00215048 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.99449863 |
| 80 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.98172982 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.97987154 |
| 82 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97691660 |
| 83 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97527505 |
| 84 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.96820247 |
| 85 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96562848 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91308977 |
| 87 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.90716445 |
| 88 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.89333477 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.88663522 |
| 90 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.88601410 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.84198170 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83852642 |
| 93 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.80656194 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79079550 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78531301 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.77175510 |
| 97 | Renin secretion_Homo sapiens_hsa04924 | 0.76205245 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.75736604 |
| 99 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.75591412 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75370136 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.74472041 |
| 102 | Measles_Homo sapiens_hsa05162 | 0.73687248 |
| 103 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72270250 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.70047622 |
| 105 | Platelet activation_Homo sapiens_hsa04611 | 0.64709642 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61800466 |
| 107 | Huntingtons disease_Homo sapiens_hsa05016 | 0.60981913 |
| 108 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60831950 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.55937257 |
| 110 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53976394 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.53710235 |
| 112 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53333764 |
| 113 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51846136 |
| 114 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48152788 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47293760 |
| 116 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.46464317 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44903948 |
| 118 | Amoebiasis_Homo sapiens_hsa05146 | 0.44662675 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.42997541 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.42590974 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42470144 |
| 122 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42142449 |
| 123 | Long-term depression_Homo sapiens_hsa04730 | 0.41223133 |
| 124 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36916170 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.35410201 |
| 126 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.33762634 |
| 127 | Adherens junction_Homo sapiens_hsa04520 | 0.33701683 |
| 128 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33650885 |
| 129 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33543939 |
| 130 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32738488 |
| 131 | Hepatitis C_Homo sapiens_hsa05160 | 0.32402425 |
| 132 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32286875 |
| 133 | Hepatitis B_Homo sapiens_hsa05161 | 0.31918814 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30523754 |
| 135 | Circadian entrainment_Homo sapiens_hsa04713 | 0.29013217 |
| 136 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28530774 |
| 137 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.26608372 |
| 138 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.25217236 |
| 139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.25013390 |
| 140 | Long-term potentiation_Homo sapiens_hsa04720 | 0.23790015 |
| 141 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23258221 |
| 142 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.23177819 |
| 143 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22058514 |
| 144 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19902482 |
| 145 | Melanogenesis_Homo sapiens_hsa04916 | 0.19661580 |
| 146 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19181046 |
| 147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.18220291 |
| 148 | Olfactory transduction_Homo sapiens_hsa04740 | 0.17952873 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.16715474 |
| 150 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.16693780 |
| 151 | Purine metabolism_Homo sapiens_hsa00230 | 0.14393306 |
| 152 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.14308618 |
| 153 | Glioma_Homo sapiens_hsa05214 | 0.13594478 |
| 154 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12743534 |
| 155 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.12697663 |
| 156 | Salivary secretion_Homo sapiens_hsa04970 | 0.11388163 |
| 157 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.11127238 |
| 158 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.11031543 |
| 159 | Sulfur relay system_Homo sapiens_hsa04122 | 0.09353950 |
| 160 | Gap junction_Homo sapiens_hsa04540 | 0.07619728 |
| 161 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.06801540 |
| 162 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.06500349 |
| 163 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.06388076 |
| 164 | Bladder cancer_Homo sapiens_hsa05219 | 0.06017813 |
| 165 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.04856044 |
| 166 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.04082848 |
| 167 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.03803249 |
| 168 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.03328646 |
| 169 | Salmonella infection_Homo sapiens_hsa05132 | 0.03241805 |

